Mobile

An evaluation of the impact of early initiation of Highly Active Anti-Retroviral Therapy (HAART) on Tuberculosis (TB) treatment outcomes for TB patients co-infected with Human Immunodeficiency Virus (...

Update Il y a 4 ans
Reference: ISRCTN77861053

An evaluation of the impact of early initiation of Highly Active Anti-Retroviral Therapy (HAART) on Tuberculosis (TB) treatment outcomes for TB patients co-infected with Human Immunodeficiency Virus (HIV)

Woman and Man

Extract

Not provided at time of registration

Inclusion criteria

  • Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) co-infections

Links